Submitted by Anonymous (not verified) on 23 October 2025 - 9:21
Opinion/decision on a Paediatric investigation plan (PIP): Volibris, ambrisentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: P/0384/2024
Source: